Stellarex 035 Drug Coated Ballon Percutaneous Transluminal Angioplasty Catheter
FDA premarket approval P160049/S018 · decided 2022-06-22
Approval details
- PMA number
- P160049
- Supplement
- S018
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Stellarex 035 Drug Coated Ballon Percutaneous Transluminal Angioplasty Catheter
- Generic name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Applicant
- The Spectranetics Corp.
- Date received
- 2022-04-01
- Decision date
- 2022-06-22
- Days to decision
- 82 days
- Decision code
- APPR
- Product code
- ONU
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Fremont, CA
- Statement
- Approval for a manufacturing site located at Philips Image Guided Therapy Corporation, 5905 Nathan Lane North, Plymouth, MN 55442 for catheter assembly of the Stellarex 035 Drug Coated Balloon.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.